New Market Study, "Analgesics in New Zealand", Has Been Published
Value sales for analgesics increased by 3% during 2012 to reach NZ$48 million. 2012 growth was higher than the review period growth of 2%. Furthermore, 2012 growth was also higher than the 2% growth observed during 2011. Higher value growth in 2012 was largely due to product innovation within combination products and effective marketing activities across the analgesics category.
View full press release